lobbying_activities: 3186443
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3186443 | 17b36376-5088-4f05-8ed9-bc351130aec6 | Q2 | RED+BLUE STRATEGIES | 400693064 | QUEST DIAGNOSTICS INCORPORATED | 2024 | second_quarter | MMM | Issues related to combatting the syphilis crisis in the United States and its impact on underserved communities. H.R. 4366 - Consolidated Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year. H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to funding of programs promulgated by the Department of Health and Human Services and its agencies, including CMS. Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2024-07-07T09:23:28-04:00 |